Singh, Rhea
Fathy, Ramie
Kassamali, Bina
Noe, Megan H.
Barbieri, John S.
LaChance, Avery
Charrow, Alexandra P.
Article History
Received: 6 June 2023
Revised: 19 September 2023
Accepted: 18 October 2023
First Online: 18 December 2023
Declarations
:
: No conflicts of interest relevant to this article.
: The authors Singh, Fathy, and Kassamali have no financial disclosures. Dr. Noe has received research funding from Boehringer Ingelheim and Bristol Myers Squibb. She served as a consultant for Boehringer Ingelheim and has received honoraria. Dr. Charrow serves on the advisory board of Novartis in a capacity not directly related to this research study. John S Barbieri has received consulting fees from Dexcel Pharma for work unrelated to the present submission.